A

pproximately 10 percent of all medicines found in low- and middle-income countries are either substandard or falsified, ranging from cancer drugs and contraceptives to antibiotics and anti-malarial treatments. And the problem is almost evenly split between patented brand-name drugs and generics, according to new reports from the World Health Organization.

Moreover, the agency maintained there is a tremendous cost – about $30 billion is spent on such medicines.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

  • The same companies that oppose imports also opposed serialization for years, which was to keep the US supply chain safe. Amazingly selective attention … as well as blindness to the falsified meds in the US supply chain already, ‘both domestic and imported.’

Sign up for our Biotech newsletter — The Readout

Your daily guide to what’s new in biotech.